28 days of creatine nitrate supplementation is apparently safe in healthy individuals View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-12-20

AUTHORS

Jordan M Joy, Ryan P Lowery, Paul H Falcone, Matt M Mosman, Roxanne M Vogel, Laura R Carson, Chih-Yin Tai, David Choate, Dylan Kimber, Jacob A Ormes, Jacob M Wilson, Jordan R Moon

ABSTRACT

BACKGROUND: Creatine monohydrate has become a very popular nutritional supplement for its ergogenic effects. The safety of creatine monohydrate has previously been confirmed. However with each novel form of creatine that emerges, its safety must be verified. Therefore, the purpose of this study was to examine the safety of a novel form of creatine, creatine nitrate (CN), over a 28 day period. METHODS: 58 young males and females (Pooled: 24.3 ± 3.9 years, 144.9 ± 8.0 cm, 74.2 ± 13.0 kg) participated in this study across two laboratories. Subjects were equally and randomly assigned to consume either 1 g (n = 18) or 2 g (n = 20) of CN or remained unsupplemented (n = 20). Blood draws for full safety panels were conducted by a trained phlebotomist prior to and at the conclusion of the supplementation period. RESULTS: Pooled data from both laboratories revealed significant group x time interactions for absolute lymphocytes and absolute monocytes (p < 0.05). Analysis of the 1 g treatment revealed lab x time differences for red blood cell distribution width, platelets, absolute monocytes, creatinine, blood urea nitrogen (BUN):creatinine, sodium, protein, and alanine aminotransferase (ALT) (p < 0.05). Analysis of the 2 g treatment revealed lab x time differences for BUN:creatinine and ALT (p < 0.05). BUN and BUN:creatinine increased beyond the clinical reference range for the 2 g treatment of Lab 2, but BUN did not reach statistical significance. CONCLUSION: Overall, CN appears to be safe in both 1 g and 2 g servings daily for up to a 28 day period. While those with previously elevated BUN levels may see additional increases resulting in post-supplementation values slightly beyond normal physiological range, these results have minor clinical significance and are not cause for concern. Otherwise, all hematological safety markers remained within normal range, suggesting that CN supplementation has no adverse effects in daily doses up to 2 g over 28 days and may be an alternative to creatine monohydrate supplementation. More... »

PAGES

60

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12970-014-0060-9

DOI

http://dx.doi.org/10.1186/s12970-014-0060-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1009284927

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25589898


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "MusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO USA", 
          "id": "http://www.grid.ac/institutes/grid.489157.6", 
          "name": [
            "Department of Health Sciences and Human Performance, The University of Tampa, Tampa, FL USA", 
            "MusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Joy", 
        "givenName": "Jordan M", 
        "id": "sg:person.01301075204.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301075204.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Health Sciences and Human Performance, The University of Tampa, Tampa, FL USA", 
          "id": "http://www.grid.ac/institutes/grid.267280.9", 
          "name": [
            "Department of Health Sciences and Human Performance, The University of Tampa, Tampa, FL USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lowery", 
        "givenName": "Ryan P", 
        "id": "sg:person.01232762004.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01232762004.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO USA", 
          "id": "http://www.grid.ac/institutes/grid.489157.6", 
          "name": [
            "MusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Falcone", 
        "givenName": "Paul H", 
        "id": "sg:person.0600551562.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600551562.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO USA", 
          "id": "http://www.grid.ac/institutes/grid.489157.6", 
          "name": [
            "MusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mosman", 
        "givenName": "Matt M", 
        "id": "sg:person.01311255132.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311255132.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO USA", 
          "id": "http://www.grid.ac/institutes/grid.489157.6", 
          "name": [
            "MusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vogel", 
        "givenName": "Roxanne M", 
        "id": "sg:person.01323652422.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323652422.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO USA", 
          "id": "http://www.grid.ac/institutes/grid.489157.6", 
          "name": [
            "MusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carson", 
        "givenName": "Laura R", 
        "id": "sg:person.01243141732.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243141732.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO USA", 
          "id": "http://www.grid.ac/institutes/grid.489157.6", 
          "name": [
            "MusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tai", 
        "givenName": "Chih-Yin", 
        "id": "sg:person.01126713332.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126713332.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Metropolitan State University, Denver, CO USA", 
          "id": "http://www.grid.ac/institutes/grid.411788.3", 
          "name": [
            "Metropolitan State University, Denver, CO USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Choate", 
        "givenName": "David", 
        "id": "sg:person.0752742220.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752742220.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Metropolitan State University, Denver, CO USA", 
          "id": "http://www.grid.ac/institutes/grid.411788.3", 
          "name": [
            "Metropolitan State University, Denver, CO USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kimber", 
        "givenName": "Dylan", 
        "id": "sg:person.01021055420.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021055420.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Health Sciences and Human Performance, The University of Tampa, Tampa, FL USA", 
          "id": "http://www.grid.ac/institutes/grid.267280.9", 
          "name": [
            "Department of Health Sciences and Human Performance, The University of Tampa, Tampa, FL USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ormes", 
        "givenName": "Jacob A", 
        "id": "sg:person.011013436313.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011013436313.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Health Sciences and Human Performance, The University of Tampa, Tampa, FL USA", 
          "id": "http://www.grid.ac/institutes/grid.267280.9", 
          "name": [
            "Department of Health Sciences and Human Performance, The University of Tampa, Tampa, FL USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wilson", 
        "givenName": "Jacob M", 
        "id": "sg:person.01164646604.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164646604.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Sports Exercise Science, United States Sports Academy, Daphne, AL USA", 
          "id": "http://www.grid.ac/institutes/grid.454691.b", 
          "name": [
            "MusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO USA", 
            "Department of Sports Exercise Science, United States Sports Academy, Daphne, AL USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moon", 
        "givenName": "Jordan R", 
        "id": "sg:person.01133414235.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133414235.98"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1550-2783-4-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047522130", 
          "https://doi.org/10.1186/1550-2783-4-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/225021a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039794677", 
          "https://doi.org/10.1038/225021a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1550-2783-7-40", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014861708", 
          "https://doi.org/10.1186/1550-2783-7-40"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1550-2783-6-16", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035390763", 
          "https://doi.org/10.1186/1550-2783-6-16"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00424-013-1220-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013766970", 
          "https://doi.org/10.1007/s00424-013-1220-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1550-2783-10-44", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024517610", 
          "https://doi.org/10.1186/1550-2783-10-44"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-12-20", 
    "datePublishedReg": "2014-12-20", 
    "description": "BACKGROUND: Creatine monohydrate has become a very popular nutritional supplement for its ergogenic effects. The safety of creatine monohydrate has previously been confirmed. However with each novel form of creatine that emerges, its safety must be verified. Therefore, the purpose of this study was to examine the safety of a novel form of creatine, creatine nitrate (CN), over a 28\u00a0day period.\nMETHODS: 58 young males and females (Pooled: 24.3\u2009\u00b1\u20093.9\u00a0years, 144.9\u2009\u00b1\u20098.0\u00a0cm, 74.2\u2009\u00b1\u200913.0\u00a0kg) participated in this study across two laboratories. Subjects were equally and randomly assigned to consume either 1\u00a0g (n\u2009=\u200918) or 2\u00a0g (n\u2009=\u200920) of CN or remained unsupplemented (n\u2009=\u200920). Blood draws for full safety panels were conducted by a trained phlebotomist prior to and at the conclusion of the supplementation period.\nRESULTS: Pooled data from both laboratories revealed significant group x time interactions for absolute lymphocytes and absolute monocytes (p\u2009<\u20090.05). Analysis of the 1\u00a0g treatment revealed lab x time differences for red blood cell distribution width, platelets, absolute monocytes, creatinine, blood urea nitrogen (BUN):creatinine, sodium, protein, and alanine aminotransferase (ALT) (p\u2009<\u20090.05). Analysis of the 2\u00a0g treatment revealed lab x time differences for BUN:creatinine and ALT (p\u2009<\u20090.05). BUN and BUN:creatinine increased beyond the clinical reference range for the 2\u00a0g treatment of Lab 2, but BUN did not reach statistical significance.\nCONCLUSION: Overall, CN appears to be safe in both 1\u00a0g and 2\u00a0g servings daily for up to a 28\u00a0day period. While those with previously elevated BUN levels may see additional increases resulting in post-supplementation values slightly beyond normal physiological range, these results have minor clinical significance and are not cause for concern. Otherwise, all hematological safety markers remained within normal range, suggesting that CN supplementation has no adverse effects in daily doses up to 2\u00a0g over 28\u00a0days and may be an alternative to creatine monohydrate supplementation.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12970-014-0060-9", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1034609", 
        "issn": [
          "1550-2783"
        ], 
        "name": "Journal of the International Society of Sports Nutrition", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "11"
      }
    ], 
    "keywords": [
      "blood urea nitrogen", 
      "creatine nitrate", 
      "alanine aminotransferase", 
      "creatine monohydrate", 
      "absolute monocytes", 
      "red blood cell distribution width", 
      "post-supplementation values", 
      "significant group x time interaction", 
      "group x time interaction", 
      "creatine monohydrate supplementation", 
      "elevated BUN levels", 
      "cell distribution width", 
      "clinical reference range", 
      "minor clinical significance", 
      "popular nutritional supplement", 
      "CN supplementation", 
      "absolute lymphocyte", 
      "BUN levels", 
      "daily doses", 
      "normal physiological range", 
      "ergogenic effect", 
      "supplementation period", 
      "clinical significance", 
      "urea nitrogen", 
      "normal range", 
      "healthy individuals", 
      "reference range", 
      "safety markers", 
      "nitrate supplementation", 
      "nutritional supplements", 
      "creatinine", 
      "adverse effects", 
      "young males", 
      "time interaction", 
      "statistical significance", 
      "day period", 
      "distribution width", 
      "supplementation", 
      "treatment", 
      "monocytes", 
      "physiological range", 
      "creatine", 
      "safety", 
      "additional increase", 
      "days", 
      "Safety Panel", 
      "novel form", 
      "period", 
      "lymphocytes", 
      "doses", 
      "blood", 
      "aminotransferase", 
      "phlebotomists", 
      "Overall", 
      "platelets", 
      "significance", 
      "differences", 
      "study", 
      "cause", 
      "males", 
      "markers", 
      "subjects", 
      "Lab 2", 
      "supplements", 
      "females", 
      "conclusion", 
      "effect", 
      "time difference", 
      "individuals", 
      "sodium", 
      "laboratory", 
      "levels", 
      "increase", 
      "protein", 
      "panel", 
      "analysis", 
      "purpose", 
      "concern", 
      "data", 
      "form", 
      "alternative", 
      "results", 
      "range", 
      "values", 
      "monohydrate", 
      "interaction", 
      "width", 
      "nitrate", 
      "nitrogen", 
      "full safety panels", 
      "x time interactions", 
      "lab x time differences", 
      "x time differences", 
      "blood cell distribution width", 
      "hematological safety markers", 
      "monohydrate supplementation", 
      "creatine nitrate supplementation"
    ], 
    "name": "28 days of creatine nitrate supplementation is apparently safe in healthy individuals", 
    "pagination": "60", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1009284927"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12970-014-0060-9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25589898"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12970-014-0060-9", 
      "https://app.dimensions.ai/details/publication/pub.1009284927"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_638.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12970-014-0060-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12970-014-0060-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12970-014-0060-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12970-014-0060-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12970-014-0060-9'


 

This table displays all metadata directly associated to this object as RDF triples.

270 TRIPLES      22 PREDICATES      129 URIs      115 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12970-014-0060-9 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N8aaedd2241254909a68064d96d0e3467
4 schema:citation sg:pub.10.1007/s00424-013-1220-5
5 sg:pub.10.1038/225021a0
6 sg:pub.10.1186/1550-2783-10-44
7 sg:pub.10.1186/1550-2783-4-6
8 sg:pub.10.1186/1550-2783-6-16
9 sg:pub.10.1186/1550-2783-7-40
10 schema:datePublished 2014-12-20
11 schema:datePublishedReg 2014-12-20
12 schema:description BACKGROUND: Creatine monohydrate has become a very popular nutritional supplement for its ergogenic effects. The safety of creatine monohydrate has previously been confirmed. However with each novel form of creatine that emerges, its safety must be verified. Therefore, the purpose of this study was to examine the safety of a novel form of creatine, creatine nitrate (CN), over a 28 day period. METHODS: 58 young males and females (Pooled: 24.3 ± 3.9 years, 144.9 ± 8.0 cm, 74.2 ± 13.0 kg) participated in this study across two laboratories. Subjects were equally and randomly assigned to consume either 1 g (n = 18) or 2 g (n = 20) of CN or remained unsupplemented (n = 20). Blood draws for full safety panels were conducted by a trained phlebotomist prior to and at the conclusion of the supplementation period. RESULTS: Pooled data from both laboratories revealed significant group x time interactions for absolute lymphocytes and absolute monocytes (p < 0.05). Analysis of the 1 g treatment revealed lab x time differences for red blood cell distribution width, platelets, absolute monocytes, creatinine, blood urea nitrogen (BUN):creatinine, sodium, protein, and alanine aminotransferase (ALT) (p < 0.05). Analysis of the 2 g treatment revealed lab x time differences for BUN:creatinine and ALT (p < 0.05). BUN and BUN:creatinine increased beyond the clinical reference range for the 2 g treatment of Lab 2, but BUN did not reach statistical significance. CONCLUSION: Overall, CN appears to be safe in both 1 g and 2 g servings daily for up to a 28 day period. While those with previously elevated BUN levels may see additional increases resulting in post-supplementation values slightly beyond normal physiological range, these results have minor clinical significance and are not cause for concern. Otherwise, all hematological safety markers remained within normal range, suggesting that CN supplementation has no adverse effects in daily doses up to 2 g over 28 days and may be an alternative to creatine monohydrate supplementation.
13 schema:genre article
14 schema:inLanguage en
15 schema:isAccessibleForFree true
16 schema:isPartOf N0973c7bab628498197a917caf6ddf704
17 N85d19bc1a7f84b4ebae19c3257b9f90b
18 sg:journal.1034609
19 schema:keywords BUN levels
20 CN supplementation
21 Lab 2
22 Overall
23 Safety Panel
24 absolute lymphocyte
25 absolute monocytes
26 additional increase
27 adverse effects
28 alanine aminotransferase
29 alternative
30 aminotransferase
31 analysis
32 blood
33 blood cell distribution width
34 blood urea nitrogen
35 cause
36 cell distribution width
37 clinical reference range
38 clinical significance
39 concern
40 conclusion
41 creatine
42 creatine monohydrate
43 creatine monohydrate supplementation
44 creatine nitrate
45 creatine nitrate supplementation
46 creatinine
47 daily doses
48 data
49 day period
50 days
51 differences
52 distribution width
53 doses
54 effect
55 elevated BUN levels
56 ergogenic effect
57 females
58 form
59 full safety panels
60 group x time interaction
61 healthy individuals
62 hematological safety markers
63 increase
64 individuals
65 interaction
66 lab x time differences
67 laboratory
68 levels
69 lymphocytes
70 males
71 markers
72 minor clinical significance
73 monocytes
74 monohydrate
75 monohydrate supplementation
76 nitrate
77 nitrate supplementation
78 nitrogen
79 normal physiological range
80 normal range
81 novel form
82 nutritional supplements
83 panel
84 period
85 phlebotomists
86 physiological range
87 platelets
88 popular nutritional supplement
89 post-supplementation values
90 protein
91 purpose
92 range
93 red blood cell distribution width
94 reference range
95 results
96 safety
97 safety markers
98 significance
99 significant group x time interaction
100 sodium
101 statistical significance
102 study
103 subjects
104 supplementation
105 supplementation period
106 supplements
107 time difference
108 time interaction
109 treatment
110 urea nitrogen
111 values
112 width
113 x time differences
114 x time interactions
115 young males
116 schema:name 28 days of creatine nitrate supplementation is apparently safe in healthy individuals
117 schema:pagination 60
118 schema:productId N5fe706d4121b431d80aa97d0677ca86a
119 Nc35fb2f51fb24a9ab9ea06e5b5aa54f3
120 Nfdaa6d2cb0544ee884b496b644f1f00a
121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009284927
122 https://doi.org/10.1186/s12970-014-0060-9
123 schema:sdDatePublished 2021-11-01T18:23
124 schema:sdLicense https://scigraph.springernature.com/explorer/license/
125 schema:sdPublisher N821bb11ef4fe47c59002e0605fe33a96
126 schema:url https://doi.org/10.1186/s12970-014-0060-9
127 sgo:license sg:explorer/license/
128 sgo:sdDataset articles
129 rdf:type schema:ScholarlyArticle
130 N0973c7bab628498197a917caf6ddf704 schema:volumeNumber 11
131 rdf:type schema:PublicationVolume
132 N1c87124347254c68acf10576e460484d rdf:first sg:person.0752742220.51
133 rdf:rest Nfe90389540814a29b0e366d1028d4f5d
134 N35ea4c7b6f0743b7ac6c8163e042200b rdf:first sg:person.01133414235.98
135 rdf:rest rdf:nil
136 N4e050dd41d8f42a1b177368b7d15d79c rdf:first sg:person.01323652422.47
137 rdf:rest N5466436183a844fb85b89b76068087bf
138 N5466436183a844fb85b89b76068087bf rdf:first sg:person.01243141732.37
139 rdf:rest Ndce1803ae3dc41438a75915ade4d6b7c
140 N5fe706d4121b431d80aa97d0677ca86a schema:name doi
141 schema:value 10.1186/s12970-014-0060-9
142 rdf:type schema:PropertyValue
143 N679fedbc7f774777a7a950da432998ce rdf:first sg:person.0600551562.94
144 rdf:rest N8872c84cd8444256a033ad68a6cd58d5
145 N821bb11ef4fe47c59002e0605fe33a96 schema:name Springer Nature - SN SciGraph project
146 rdf:type schema:Organization
147 N85d19bc1a7f84b4ebae19c3257b9f90b schema:issueNumber 1
148 rdf:type schema:PublicationIssue
149 N8872c84cd8444256a033ad68a6cd58d5 rdf:first sg:person.01311255132.04
150 rdf:rest N4e050dd41d8f42a1b177368b7d15d79c
151 N8aaedd2241254909a68064d96d0e3467 rdf:first sg:person.01301075204.85
152 rdf:rest Nab6c1617b61f4c1bb5bab79f3b3b2e4d
153 Nab6c1617b61f4c1bb5bab79f3b3b2e4d rdf:first sg:person.01232762004.15
154 rdf:rest N679fedbc7f774777a7a950da432998ce
155 Nc2d23edca3784ccfa5455a9e5c3108f1 rdf:first sg:person.011013436313.81
156 rdf:rest Nfbde014e08f34b939ce6b87abb55ac9e
157 Nc35fb2f51fb24a9ab9ea06e5b5aa54f3 schema:name pubmed_id
158 schema:value 25589898
159 rdf:type schema:PropertyValue
160 Ndce1803ae3dc41438a75915ade4d6b7c rdf:first sg:person.01126713332.03
161 rdf:rest N1c87124347254c68acf10576e460484d
162 Nfbde014e08f34b939ce6b87abb55ac9e rdf:first sg:person.01164646604.47
163 rdf:rest N35ea4c7b6f0743b7ac6c8163e042200b
164 Nfdaa6d2cb0544ee884b496b644f1f00a schema:name dimensions_id
165 schema:value pub.1009284927
166 rdf:type schema:PropertyValue
167 Nfe90389540814a29b0e366d1028d4f5d rdf:first sg:person.01021055420.28
168 rdf:rest Nc2d23edca3784ccfa5455a9e5c3108f1
169 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
170 schema:name Medical and Health Sciences
171 rdf:type schema:DefinedTerm
172 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
173 schema:name Clinical Sciences
174 rdf:type schema:DefinedTerm
175 sg:journal.1034609 schema:issn 1550-2783
176 schema:name Journal of the International Society of Sports Nutrition
177 schema:publisher Springer Nature
178 rdf:type schema:Periodical
179 sg:person.01021055420.28 schema:affiliation grid-institutes:grid.411788.3
180 schema:familyName Kimber
181 schema:givenName Dylan
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021055420.28
183 rdf:type schema:Person
184 sg:person.011013436313.81 schema:affiliation grid-institutes:grid.267280.9
185 schema:familyName Ormes
186 schema:givenName Jacob A
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011013436313.81
188 rdf:type schema:Person
189 sg:person.01126713332.03 schema:affiliation grid-institutes:grid.489157.6
190 schema:familyName Tai
191 schema:givenName Chih-Yin
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126713332.03
193 rdf:type schema:Person
194 sg:person.01133414235.98 schema:affiliation grid-institutes:grid.454691.b
195 schema:familyName Moon
196 schema:givenName Jordan R
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133414235.98
198 rdf:type schema:Person
199 sg:person.01164646604.47 schema:affiliation grid-institutes:grid.267280.9
200 schema:familyName Wilson
201 schema:givenName Jacob M
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164646604.47
203 rdf:type schema:Person
204 sg:person.01232762004.15 schema:affiliation grid-institutes:grid.267280.9
205 schema:familyName Lowery
206 schema:givenName Ryan P
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01232762004.15
208 rdf:type schema:Person
209 sg:person.01243141732.37 schema:affiliation grid-institutes:grid.489157.6
210 schema:familyName Carson
211 schema:givenName Laura R
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243141732.37
213 rdf:type schema:Person
214 sg:person.01301075204.85 schema:affiliation grid-institutes:grid.489157.6
215 schema:familyName Joy
216 schema:givenName Jordan M
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301075204.85
218 rdf:type schema:Person
219 sg:person.01311255132.04 schema:affiliation grid-institutes:grid.489157.6
220 schema:familyName Mosman
221 schema:givenName Matt M
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311255132.04
223 rdf:type schema:Person
224 sg:person.01323652422.47 schema:affiliation grid-institutes:grid.489157.6
225 schema:familyName Vogel
226 schema:givenName Roxanne M
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323652422.47
228 rdf:type schema:Person
229 sg:person.0600551562.94 schema:affiliation grid-institutes:grid.489157.6
230 schema:familyName Falcone
231 schema:givenName Paul H
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600551562.94
233 rdf:type schema:Person
234 sg:person.0752742220.51 schema:affiliation grid-institutes:grid.411788.3
235 schema:familyName Choate
236 schema:givenName David
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752742220.51
238 rdf:type schema:Person
239 sg:pub.10.1007/s00424-013-1220-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013766970
240 https://doi.org/10.1007/s00424-013-1220-5
241 rdf:type schema:CreativeWork
242 sg:pub.10.1038/225021a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039794677
243 https://doi.org/10.1038/225021a0
244 rdf:type schema:CreativeWork
245 sg:pub.10.1186/1550-2783-10-44 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024517610
246 https://doi.org/10.1186/1550-2783-10-44
247 rdf:type schema:CreativeWork
248 sg:pub.10.1186/1550-2783-4-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047522130
249 https://doi.org/10.1186/1550-2783-4-6
250 rdf:type schema:CreativeWork
251 sg:pub.10.1186/1550-2783-6-16 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035390763
252 https://doi.org/10.1186/1550-2783-6-16
253 rdf:type schema:CreativeWork
254 sg:pub.10.1186/1550-2783-7-40 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014861708
255 https://doi.org/10.1186/1550-2783-7-40
256 rdf:type schema:CreativeWork
257 grid-institutes:grid.267280.9 schema:alternateName Department of Health Sciences and Human Performance, The University of Tampa, Tampa, FL USA
258 schema:name Department of Health Sciences and Human Performance, The University of Tampa, Tampa, FL USA
259 rdf:type schema:Organization
260 grid-institutes:grid.411788.3 schema:alternateName Metropolitan State University, Denver, CO USA
261 schema:name Metropolitan State University, Denver, CO USA
262 rdf:type schema:Organization
263 grid-institutes:grid.454691.b schema:alternateName Department of Sports Exercise Science, United States Sports Academy, Daphne, AL USA
264 schema:name Department of Sports Exercise Science, United States Sports Academy, Daphne, AL USA
265 MusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO USA
266 rdf:type schema:Organization
267 grid-institutes:grid.489157.6 schema:alternateName MusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO USA
268 schema:name Department of Health Sciences and Human Performance, The University of Tampa, Tampa, FL USA
269 MusclePharm Sports Science Institute, MusclePharm Corp., Denver, CO USA
270 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...